Product | MedDrive™

INFOGRAPHIC

Leveraging the collective strength of Prime’s client membership to help control medical costs including biosimilars, medical rebates and low net cost savings.

Related news

Press releases

May 26, 2021

Prime Therapeutics launches MedDrive™, a first-of-its kind medical drug management program uniquely aligned with its Blue Plan clients

EAGAN, Minn. – Today, Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM)…

Press releases

November 3, 2021

Prime Therapeutics backs first interchangeable insulin biosimilar Semglee®

EAGAN, Minn. – Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM)…

Stories

September 8, 2021

Prime leaders appear on PCMA’s podcast on topic “Understanding the value of biosimilars”

Today, spending on biologic drugs makes up 43% of total drug spending. This…